Addition of 6 months of androgen deprivation therapy to stereotactic body radiotherapy more than doubled PFS in hormone-sensitive oligorecurrent prostate cancer. Nearly all patients treated with the ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) announced today that the latest results from that follicular lymphoma clinical trial have shown the three-drug combination — rituximab ...

Share on Pinterest A new study explores the effects of diet and exercise in preventing weight gain. Design by MNT; Photography by Nadine Greeff/Stocksy & BONNINSTUDIO/Stocksy Over the last few years, ...

Next up in The Haunted Floating Festival is the Combination Puzzle, which is the strange numbered pillars with symbols you can turn. You can find it opposite the fast-travel well on the island. To ...

Results from sub-study 03A of KEYMAKER-U03, an international, open-label, rolling-arm, phase I/II umbrella trial, spotlight the promise of pembrolizumab-based regimens combined with tyrosine kinase ...

WILMINGTON, Del.--(BUSINESS WIRE)--Synnovation Therapeutics, a precision medicine company focused on the discovery and development of best-in-class targeted medicines, today announced that it will be ...

Barcelona, Spain (September, 2025) —A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in ...

There are quite a few locked safes that you'll encounter throughout Mafia: The Old Country. Some of these are required to progress the main story, while others are ...

OpenAI has launched a new “study mode” for ChatGPT that’s designed to help students better understand complex topics—but instead of dishing out direct answers, study mode employs the Socratic method ...

Corbus Pharmaceuticals initiates combination cohort of CRB-701 study for solid tumors, focusing on HNSCC and cervical cancer. Data update expected this year. Corbus Pharmaceuticals Holdings, Inc.

A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a brain tumor diagnosis with few available effective treatments. According to ...

Efficacy and CNS results from a randomized subset of the phase 2 SAVANNAH study comparing savolitinib (savo) + osimertinib (osi) combination with savo + placebo (PBO). This is an ASCO Meeting Abstract ...